Our Markets

Novasep Press Releases

For the latest news from Novasep, please click on the press release below that you are interested in.

Novasep appoints a new Chairman for its Supervisory Board - Bernard Dubois, former Aventis Senior VP of Global Industrial Operations - 01/09/2010

Pompey, France, September 1, 2010 – Novasep, a leading supplier of manufacturing solutions to the life science industries, announces the appointment of Bernard Dubois as Chairman of its supervisory board. Bernard Dubois replaces Pietro Stefanutti, who decided to allocate most ...

Cerenis Therapeutics and Novasep awarded EUR 10.7 million funding from the French Government for the development CER-001, an HDL mimetic - 26/07/2010

July 26, 2010 - Toulouse and Pompey, France: Cerenis Therapeutics SA (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe Novasep (Novasep), a leading supplier of manufacturing ...

Novasep and instrAction enter into a worldwide strategic alliance for non-chiral chromatography - 19/07/2010

Combination of instrAction and Novasep know-how sets a new standard for small molecule purification processes for the life science industries Pompey, France and Ludwigshafen, Germany, 19th July 2010 -- Novasep, a leading supplier of manufacturing solutions to the life science ...

Novasep appoints two key executives - 03/05/2010

Stephen Stefano heads up Novasep North American business and Patrick Glaser leads Novasep Synthesis division Pompey, France, May 3rd, 2010 – Novasep, a leading supplier of manufacturing solutions to the life sciences industries, announces today the appointments of two ...

Provepharm announces acceptance of Proveblue® injectable drug MAA for review under EMEA centralized procedure and validation by Novasep of API cGMP process - 11/02/2010

Pompey and Marseille, France, February 11 2010 Novasep, a leading supplier of manufacturing solutions to the life sciences industries, and Provepharm, a start-up specialized in the development of pharmaceutical applications for Proveblue®, announce today the successful validation ...